Medical News

March 3, 2004 — Arrow International, headquartered in Reading, Pennsylvania, USA, develops, manufactures and markets a broad range of disposable catheters and related products for critical and cardiac care. Arrow’s critical care products are principally used for central venous access in the administration of fluids, drugs and blood products, as well as for patient monitoring, diagnosis and pain management. The company’s cardiac assist products are used in the diagnosis and treatment of patients with heart and vascular disease and to provide short-term cardiac assist following cardiac surgery, serious heart attack or balloon angioplasty. In fiscal 2003, Arrow’s revenue increased by 11.6% to US$380.4 million, while gross profits rose by 11.1% to US$190.1 million.

In the US, Arrow’s principal manufacturing site is the Reading facility, with other facilities located in Wyomissing, Pennsylvania; Asheboro, North Carolina; San Antonio, Texas; and Mount Holly, New Jersey. In addition, Arrow has manufacturing facilities in Mexico and the Czech Republic.

For a complete index of this report click on http://www.researchandmarkets.com/reports/45324

About Research and Markets Ltd.
Research and Markets Ltd. are Europe’s largest resource for market research. R&M distribute thousands of major research publications from the world’s leading publishers, consultants and market analysts. R&M provide you with the latest forecasts on international and regional markets, key industries, the top companies, new products and the latest market trends.

For additional information on ResearchandMarkets.com, their range of reports or their value-added services, visit their web site at http://www.researchandmarkets.com or mailto:press@researchandmarkets.com

March 3, 2004 — Arrow International, headquartered in Reading, Pennsylvania, USA, develops, manufactures and markets a broad range of disposable catheters and related products for critical and cardiac care. Arrow’s critical care products are principally used for central venous access in the administration of fluids, drugs and blood products, as well as for patient monitoring, diagnosis and pain management. The company’s cardiac assist products are used in the diagnosis and treatment of patients with heart and vascular disease and to provide short-term cardiac assist following cardiac surgery, serious heart attack or balloon angioplasty. In fiscal 2003, Arrow’s revenue increased by 11.6% to US$380.4 million, while gross profits rose by 11.1% to US$190.1 million.

In the US, Arrow’s principal manufacturing site is the Reading facility, with other facilities located in Wyomissing, Pennsylvania; Asheboro, North Carolina; San Antonio, Texas; and Mount Holly, New Jersey. In addition, Arrow has manufacturing facilities in Mexico and the Czech Republic.

For a complete index of this report click on http://www.researchandmarkets.com/reports/45324

About Research and Markets Ltd.
Research and Markets Ltd. are Europe’s largest resource for market research. R&M distribute thousands of major research publications from the world’s leading publishers, consultants and market analysts. R&M provide you with the latest forecasts on international and regional markets, key industries, the top companies, new products and the latest market trends.

For additional information on ResearchandMarkets.com, their range of reports or their value-added services, visit their web site at http://www.researchandmarkets.com or mailto:press@researchandmarkets.com